Telomerase reverse transcriptase-based therapies Grant US-11529396-B2 United States of America 20 Dec 2022
TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES Application EP-3978031-A1 European Patent Office 06 Apr 2022
Telomerase reverse transcriptase-based therapies for treatment of conditions associated… Grant US-11261434-B2 United States of America 01 Mar 2022
Methods of predicting mortality risk by determining telomere length Grant US-11193169-B2 United States of America 07 Dec 2021